Stock Split History
ETFs Holding IOVA »    IOVA Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Iovance Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of of cell therapies as cancer immunotherapy products. Co.'s key product candidates include lifileucel for metastatic melanoma and LN-145 for metastatic cervical cancer. In addition, Co. is investigating the effectiveness and safety of tumor infiltrating lymphocyte therapy for the treatment of squamous cell carcinoma of the head and neck, non-small cell lung cancer, and peripheral blood lymphocyte therapy for treatment of chronic lymphocytic leukemia through its sponsored trials, as well as in other oncology indications through collaborations. According to our Iovance Biotherapeutics stock split history records, Iovance Biotherapeutics has had 0 splits.
Iovance Biotherapeutics stock split history picture
Iovance Biotherapeutics (IOVA) has 0 splits in our Iovance Biotherapeutics stock split history database.

Looking at the Iovance Biotherapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Iovance Biotherapeutics shares, starting with a $10,000 purchase of IOVA, presented on a split-history-adjusted basis factoring in the complete Iovance Biotherapeutics stock split history. Iovance Biotherapeutics split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/21/2012
End date: 08/18/2022
Start price/share: $0.45
End price/share: $12.38
Dividends collected/share: $0.00
Total return: 2,651.11%
Average Annual Total Return: 39.31%
Starting investment: $10,000.00
Ending investment: $275,060.64
Years: 10.00
Date Ratio
TD Holdings, Inc. (GLG )
Iterum Therapeutics plc (ITRM)
Root, Inc. (ROOT)
Mind Medicine Inc. (MNED)
Greenlane Holdings, Inc. (GNLN)
U.S. Well Services, Inc. (USWS)
Nutriband Inc. (NTRB)
Exela Technologies, Inc. (XELA)
Motus GI Holdings, Inc. (MOTS)
Cellectar Biosciences, Inc. (CLRB)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding Iovance Biotherapeutics
Iovance Biotherapeutics Insider Buying

Iovance Biotherapeutics Stock Split History | | Copyright © 2013 - 2022, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.